×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results
PR Newswire
PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the...
2 days ago
Kintara Therapeutics Reports Improved Q3 Results - TipRanks.com
Tipranks
Kintara Therapeutics Inc (KTRA) has released an update. Kintara Therapeutics, a biopharmaceutical developer of solid tumor cancer therapies, has reported a...
2 days ago
Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update
PR Newswire
PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the...
3 months ago
KTRA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Kintara Therapeutics, Inc. Is Fair to ...
Business Wire
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Kintara Therapeutics, Inc. (NASDAQ: KTRA) and TuHURA...
1 month ago
Kintara Therapeutics And TuHURA Biosciences To Merge
Contract Pharma
The combined company will focus on advancing TuHURA's personalized cancer vaccines and first-in-class bi-functional ADCS.
2 months ago
Why Is Kintara Therapeutics (KTRA) Stock Up 103% Today?
InvestorPlace
Kintara Therapeutics stock is rising higher on Wednesday as KTRA investors react to a merger plan with TuHURA Biosciences.
1 month ago
Why Kintara Therapeutics Shares Are Gaining Today - Kintara Therapeutics (NASDAQ:KTRA)
Benzinga
Kintara Therapeutics, Inc. KTRA-3.60%. + Free Alerts. shares are trading higher in the premarket session on Wednesday with heavy volume.
1 month ago
Kintara (KTRA) Stock Soars on Merger Agreement With TuHURA
Zacks Investment Research
Kintara Therapeutics, Inc.'s ( KTRA Quick Quote KTRA - Free Report) shares surged 63.4% on Apr 3 after the company inked a definitive merger...
1 month ago
Kintara broadens REM-001 study to include key drug
Investing.com
SAN DIEGO - Kintara Therapeutics, Inc. (NASDAQ:KTRA), a biopharmaceutical company specializing in the development of novel cancer therapies,...
1 month ago
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
PR Newswire
TuHURA is planning to advance a single Phase 3 trial for IFx-2.0 personalized cancer vaccine as adjunctive therapy with Keytruda® in...
1 month ago